Repligen Corporation

RGEN·NasdaqGS·Healthcare
Compare
178.20−0.07 (−0.04%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close178.27
Open183.40
Day range174.39188.50
52-week range100.99198.87
Off day high−5.46%
Off 52-week high−10.39%
Volume1.06M
Avg. volume (3M)1.19M
Market cap11.39B
EPS (TTM)-0.2100
Forward P/E67.14
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.12
Shares outstanding63.92M
Short interest11.28% of float
Earnings dateOct 27, 2026
Analyst target203.45
Profit margin−1.47%

Against its peers

Compare in full ›
RGEN SRT.F ALIF-B.ST 688289.SS BLFS DIM.PA
Market cap 11.39B 15.64B 22.85B 9.15B — 22.17B
P/E (TTM) — 71.7 35.6 83.8 — 68.4
Forward P/E 67.1 34.5 59.0 20.2 — 37.6
Price/book 4.8 5.8 3.8 1.3 — 5.1
Dividend yield — 0.32% 0.81% 3.36% — 0.31%
1-year change +22.24% +27.63% −7.02% −28.21% — +15.24%
Today −0.04% −0.66% +1.63% +0.89% 0.00% +1.88%

The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.

Related companies

Compare ›

Other companies in Medical Instruments & Supplies, closest in size first.

Company Mkt cap Price Today
The Cooper Companies, Inc.COO · San Ramon, CAOdds 12.25B 64.42 +5.90%
Align Technology, Inc.ALGN · Tempe, AZ 11.71B 164.90 +8.79%
Daiken Medical Co., Ltd.7775.T · Izumi, Japan 11.95B 416.00 +0.24%
Avantor, Inc.AVTR · Radnor, PA 10.60B 15.65 +0.38%
Shenyang Xingqi Pharmaceutical Co.,Ltd.300573.SZ · Shenyang, China 12.89B 36.32 +0.78%
Angelalign Technology Inc.6699.HK · Shanghai, China 13.74B 80.050 +2.04%
Autek China Inc.300595.SZ · Hefei, China 9.65B 10.79 +1.60%
Baxter International Inc.BAX · Deerfield, IL 13.71B 26.50 +3.96%

Also based in Waltham, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Waltham, MA 261.64B 706.16 +1.12%
Veralto CorporationVLTO · Waltham, MA 28.45B 117.02 +0.60%
Revvity, Inc.RVTY · Waltham, MA 17.79B 159.43 −2.48%
Spyre Therapeutics, Inc.SYRE · Waltham, MA 9.26B 99.04 −0.23%
Pegasystems Inc.PEGA · Waltham, MA 5.62B 34.36 +0.03%
Cogent Biosciences, Inc.COGT · Waltham, MA 5.46B 31.49 +1.38%
Crane NXT, Co.CXT · Waltham, MA 3.55B 61.62 +2.63%
Dyne Therapeutics, Inc.DYN · Waltham, MA 3.46B 18.54 +2.71%

The stocks whose daily moves over the past year went most closely with Repligen's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Thermo Fisher Scientific Inc.TMO · Correlation 0.66 261.64B 706.16 +1.12%
Danaher CorporationDHR · Correlation 0.63 165.15B 234.93 +2.09%
Revvity, Inc.RVTY · Correlation 0.60 17.79B 159.43 −2.48%
Azenta, Inc.AZTA · Correlation 0.51 1.71B 39.14 +5.39%
Sartorius Stedim Biotech S.A.DIM.PA · Correlation 0.50 22.17B 227.80 +1.88%
Bio-Techne CorporationTECH · Correlation 0.46 11.42B 72.73 +0.10%
Avantor, Inc.AVTR · Correlation 0.45 10.60B 15.65 +0.38%
Solventum CorporationSOLV · Correlation 0.36Odds 15.21B 89.35 +5.42%

What visitors to Repligen's page also look at.

Company Mkt cap Price Today
Neurocrine Biosciences, Inc.NBIX 16.81B 166.05 +0.73%
QuidelOrtho CorporationQDEL 984.06M 14.35 +1.85%
NovoCure LimitedNVCR 1.71B 14.61 +8.79%
STAAR Surgical CompanySTAA 1.36B 27.17 +7.95%
Insulet CorporationPODD 11.44B 165.02 +6.56%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All RGEN news ›
The Globe and Mail·Positive

Repligen (RGEN) Receives a Buy from J.P. Morgan

J.P. Morgan analyst Casey Woodring maintained a Buy rating on Repligen yesterday and set a price target of $200.00. The company’s shares closed yesterday at $175.42. According to TipRanks, Woodring is a 5-star analyst with an average…

REGNRGENREPL
Markets Daily·Positive

Repligen (NASDAQ:RGEN) Price Target Raised to $180.00

Posted by Kim Johansen on Oct 22nd, 2026 Repligen (NASDAQ:RGEN – Free Report) had its price target increased by Canaccord Genuity Group from $145.00 to $180.00 in a report published on Monday, Marketbeat reports. Canaccord Genuity Group…

REGNBIIBMS
GlobeNewswire News Room·

Repligen to Report Third Quarter 2026 Financial Results

GlobeNewswire 13, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announced that the Company will report its third quarter 2026 financial results on Tuesday, October 27, 2026 The Company will issue a press release before…

RGEN

From the 4Search news index, newest first.

In the news

22mentions in 30 days
20with it in the headline
Positivesentiment

Mentioned with

Repligen Corporation11Biogen6Regeneron6Biolife Solutions5Fidelity Brokerage Services Llc5Regeneron Pharmaceuticals5Eli Lilly4Alphastreet Newsdesk3

People in the coverage

Olivier Loeillot12Kim Johansen6Libtayo5Marketbeat5Andrew Worden4Corvex4

Themes

Healthcare15SEC Filings12Biotechnology7Form 46Earnings5Regn5Form 1444Proposed Share Sale4

Most coverage from

  1. stocktitan.net8
  2. seekingalpha.com5
  3. globenewswire.com2
  4. themarketsdaily.com2
  5. contractpharma.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance